Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Licai Pharmaceutical is a comprehensive pharmaceutical enterprise based in Xi'an, China, specializing in the research, development, and large-scale manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company operates modern, GMP-certified production facilities capable of producing various dosage forms, including tablets, capsules, and granules. Its commercial portfolio is diverse, featuring treatments for respiratory infections, cardiovascular conditions, and metabolic disorders like Type 2 diabetes. Shaanxi Licai is a key player in the regional pharmaceutical industry, focusing on providing high-quality generic formulations and proprietary herbal extracts to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Licai Pharmaceutical.